Matthew Strobeck, Director at BIODESIX INC (BDSX), bought 40,000 shares at $1.40 ($56K) on 2024-11-05, disclosed to the SEC on 2024-11-06.
Open-market purchase of $56k BDSX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 4,000 | $6K | 10.0% |
| 2 | $1.40 | 36,000 | $50K | 90.0% |
| Total | $1.40 avg | 40,000 | $56K | 100% |
| Filing → |
| BDSX | BUY | 2022-11-21 | $5.4M | — | Filing → |
| BDSX | BUY | 2022-04-11 | $2.0M | — | Filing → |
| BDSX | BUY | 2022-01-04 | $643K | — | Filing → |